Lehigh Valley Health Network

LVHN Scholarly Works
Department of Medicine

The Complication of Migration: To Place or Not to
Place an Inferior Vena Cava Filter?
Courtney Bennett DO
Lehigh Valley Health Network, Courtney_E.Bennett@lvhn.org

Stacey Smith MD
Lehigh Valley Health Network, Stacey_J.Smith@lvhn.org

Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine
Part of the Medical Sciences Commons, and the Medical Specialties Commons
Published In/Presented At
Bennett, C., & Smith, S. (2010). The complication of migration: To place or not to place an inferior vena cava filter. Poster presentation.

This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.

The Complication of Migration: To place or not to place an inferior vena cava filter?
Courtney Bennett, D.O., Stacy Smith, M.D. • Lehigh Valley Health Network Allentown, Pennsylvania

INTRODUCTION
The morbidity and mortality of pulmonary emboli (PE) and deep venous
thrombosis (DVT) are significant. PE is responsible for approximately
1,2
200,000 deaths in the U.S. per year. Inferior Vena Cava (IVC) filters are
percutaneous, metal devices placed for prevention of DVT from embolizing to
the pulmonary vasculature. The efficacy of the filters is controversial, as noted
in a recent systematic review in which no recommendations could be made
3
regarding their effectiveness based on the available data. They are placed to
prevent a potentially fatal PE, but there are also possible complications.
CASE
A 17-year old male presented to the Emergency Department September
5, 2009 complaining of severe right-sided abdominal pain. The pain began
suddenly on the day of presentation, was sharp in quality and radiated to the
epigastrum. He had a significant history of left knee arthroscopy with ACL
repair on August 13, 2009 and subsequent postoperative left lower extremity
DVT. His medical history is also complicated by a left thigh hematoma and
evacuation following initiation of warfarin therapy for his lower extremity DVT.
After the thigh hematoma, the warfarin was discontinued and an IVC filter
was placed.
On evaluation of a CT scan of the abdomen and pelvis for his abdominal
pain, it was noted that the IVC filter had migrated caudally and there was
possible perforation of the filter into the duodenum. He was admitted to the
MICU and the filter was retrieved via Interventional Radiology. There was no
extravasation of the contrast to suggest caval perforation, but the radiologist
noted that there was a centering strut missing from the filter.
A CT scan of the chest without contrast demonstrated that a bent filter strut
was located in the right heart, extending from the base of the tricuspid valve
into the proximal right ventricle. This was further evaluated by echocardiogram,
which demonstrated mobile elements with lodgment in the right atrial/IVC
juncture. Interventional Radiology retrieval was unsuccessful, partly due to
multiple episodes of ventricular tachycardia from manipulation.
He was monitored in the hospital until the decision was made to leave
the strut in the heart with likely granulation of the strut. Open heart surgery
was considered and they did not proceed due to the stability of the strut on
imaging. A follow-up CT scan on January 29, 2010 demonstrated that the
strut was unchanged in position from discharge.
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CONCLUSION
This case demonstrates two reported complications of vena
cava interruption, filter migration and filter fracture. There
are multiple case reports describing cardiac tamponade
4-7
secondary to filter migration and fracture. To date, the
PREPIC Study Group is the only prospective trial evaluating
8
to benefit of IVC filter use. The study compared the use of
anticoagulation alone to the placement of an IVC filter and
anticoagulation. The primary outcome was occurrence of
symptomatic pulmonary embolism. The patients included in
this study where older with proximal DVT. They found that
IVC filters reduced the risk of PE, but increased the risk of
DVT and had no benefit on survival at eight years. There was
no statistical significance of the rate of symptomatic PE at
two years. Fifty percent of PE in the no-filter group occurred
between two and eight years. The study considers the use
of IVC filters and anticoagulation to be beneficial in high risk
patients, which they described as 1) having a PE as the initial
event, 2) PE in a non-surgical situation, and 3) idiopathic or
cancer-associated PE. This patient’s initial DVT was located
in the left posterior tibial and peroneal veins and a repeat
venous duplex prior the IVC filter placement demonstrated
no evidence for deep vein thrombosis and resolution of the
previously noted left calf DVT. In total, he had four venous
duplex studies completed after the initial diagnosis, which
were all negative for DVT. This case poses the question of the
necessity of the intervention. He presented with a DVT without
other comorbidities and the DVT was surgery related. His
complications are rare, but there are case reports describing
the potentially fatal outcomes of these complications. The
occurrences of these complications are listed in Table 1.

Figure 1.
Fluoroscopic
image of caudally
migrated IVC filter
prior to retrieval

Figure 2.
CT scan of
the chest with
centering strut
visualized in right
atria 9/17/09

Figure 3.
CT scan of
the chest with
centering strut
visualized
in right atria
1/29/10

TABLE 1
Reported Complication

Percentage (%)

Pulmonary Embolism

2-5%

Fatal Pulmonary Embolism

0.7%

Death Linked to Intervention

0.12%

Complications from Intervention

4-11%

Venous Insertion Site Thrombosis

2-28%

Migration

3-69%

Penetration

9-24%

Obstruction

6-30%

Venous Insufficiency

5-59%

Filter Fracture

1%

Guide Wire Entrapment

<1%

Adapted from: Update in Inferior Vena Cava Filters JVIR April 2003 2

There are guidelines that have been defined by the American College of Chest Physicians
for the use of vena caval interruption, which are: 9
1.	Routine use of vena cava filter in addition to anticoagulants in not recommended (Grade 1A).
2.	Placement of an inferior vena cava filter is recommended in patients with acute proximal DVT,
if anticoagulant therapy is not possible because of the risk of bleeding (Grade 1C).
3.	In patients with an IVC filter placed as an alternative to anticoagulation, it is recommended
to subsequently treat with a conventional course of anticoagulant therapy if the bleeding risk
resolves (Grades 1C).
Although complication rates of IVC filter placement have greatly improved, the risks are
still present. This case is an excellent reminder of the importance of understanding the
indications of an intervention, its effectiveness, and the potential complications.
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